These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 9380259)
61. The role of free radicals in the aging brain and Parkinson's Disease: convergence and parallelism. Kumar H; Lim HW; More SV; Kim BW; Koppula S; Kim IS; Choi DK Int J Mol Sci; 2012; 13(8):10478-10504. PubMed ID: 22949875 [TBL] [Abstract][Full Text] [Related]
62. Cytotoxic and genotoxic potential of dopamine. Stokes AH; Hastings TG; Vrana KE J Neurosci Res; 1999 Mar; 55(6):659-65. PubMed ID: 10220107 [TBL] [Abstract][Full Text] [Related]
63. A proposed dual role of neuromelanin in the pathogenesis of Parkinson's disease. Zecca L; Zucca FA; Albertini A; Rizzio E; Fariello RG Neurology; 2006 Oct; 67(7 Suppl 2):S8-11. PubMed ID: 17030740 [TBL] [Abstract][Full Text] [Related]
64. Biosynthesis, structure, and function of neuromelanin and its relation to Parkinson's disease: a critical update. d'Ischia M; Prota G Pigment Cell Res; 1997 Dec; 10(6):370-6. PubMed ID: 9428003 [TBL] [Abstract][Full Text] [Related]
65. Altered brain metabolism of iron as a cause of neurodegenerative diseases? Gerlach M; Ben-Shachar D; Riederer P; Youdim MB J Neurochem; 1994 Sep; 63(3):793-807. PubMed ID: 7519659 [TBL] [Abstract][Full Text] [Related]
66. SU-E-I-78: Neuromelanin in the Subthalamic Nucleus of Patients with Parkinson's Disease: An Electron Spin Resonance Spectroscopy Study. Gomez J; Salmon CG; Filho OB; Santos JP; Pitella J Med Phys; 2012 Jun; 39(6Part5):3643. PubMed ID: 28517656 [TBL] [Abstract][Full Text] [Related]
67. Label-Free Nanoimaging of Neuromelanin in the Brain by Soft X-ray Spectromicroscopy. Brooks J; Everett J; Lermyte F; Tjhin VT; Banerjee S; O'Connor PB; Morris CM; Sadler PJ; Telling ND; Collingwood JF Angew Chem Int Ed Engl; 2020 Jul; 59(29):11984-11991. PubMed ID: 32227670 [TBL] [Abstract][Full Text] [Related]
68. [The role of iron in the pathology of nervous system]. Tynecka M Neurol Neurochir Pol; 1995; 29(3):409-17. PubMed ID: 7566416 [TBL] [Abstract][Full Text] [Related]
69. On the functional of neuromelanin. Smythies J Proc Biol Sci; 1996 Apr; 263(1369):487-9. PubMed ID: 8637929 [TBL] [Abstract][Full Text] [Related]
71. Kinetic Modeling of pH-Dependent Oxidation of Dopamine by Iron and Its Relevance to Parkinson's Disease. Sun Y; Pham AN; Hare DJ; Waite TD Front Neurosci; 2018; 12():859. PubMed ID: 30534046 [TBL] [Abstract][Full Text] [Related]
72. Modulation by neuromelanin of the availability and reactivity of metal ions. Swartz HM; Sarna T; Zecca L Ann Neurol; 1992; 32 Suppl():S69-75. PubMed ID: 1510383 [TBL] [Abstract][Full Text] [Related]
73. Parkinson's disease and free radicals. Mechanism of neurodegeneration and neuroprotection. Kondo T Ann N Y Acad Sci; 1996 Jun; 786():206-16. PubMed ID: 8687020 [No Abstract] [Full Text] [Related]
74. Neuromelanin: a key to Parkinson's disease. Prota G; d'Ischia M Pigment Cell Res; 1993 Oct; 6(5):333-5. PubMed ID: 8302771 [No Abstract] [Full Text] [Related]
78. Neurotoxic effects of tetrahydroisoquinolines and underlying mechanisms. Surh YJ; Kim HJ Exp Neurobiol; 2010 Sep; 19(2):63-70. PubMed ID: 22110343 [TBL] [Abstract][Full Text] [Related]
79. The action spectra of free radicals produced by the irradiation of keratin containing bound iron (III) ions. Smith GJ; Claridge RF; Smith CJ Photochem Photobiol; 1979 Apr; 29(4):777-9. PubMed ID: 451015 [No Abstract] [Full Text] [Related]